Latest Breaking News On - Burns mcclellan inc - Page 1 : comparemela.com

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders,

United statesCameron radinovic lee rothJuan sanchezCellular therapies incBurns mcclellan incExchange commissionAmerican society of clinical psychopharmacologyCorporate communicationsCellular therapiesAmerican societyClinical psychopharmacologyAnnual meetingPatients with major depressive disorderBipolar disorderAnxious distressMajor depressive disorder

vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update

vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Paul sekhriLee rothDburns mcclellanSelina husain robert flammBurns mcclellan incResearch development rd expensesTv therapeutics incRd fundQuarter financial resultsProvides corporateChief executive officerMiddle eastRedeemable noncontrolling interestStockholder equityConsolidated statementsAnnual report

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJuan sanchezLas vegasLee rothCameron radinovicBurns mcclellan incGlobenewswire incCorporate communicationsCellular therapies incCellular therapiesMarkets global healthcareAmerica healthcare conferenceInvestor relations

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares

NEW YORK, April 24, 2024 Intra-Cellular Therapies, Inc. , a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders,.

United statesNew yorkCameron radinovicCanaccord genuityJuan sanchezMorgan stanley coCapital marketsExchange commissionSyndicate departmentProspectus departmentNeedham companyJp morgan securitiesMorgan stanleyCorporate communicationsCellular therapies incBroadridge financial solutions

Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference

NEW YORK, Feb. 27, 2024 Intra-Cellular Therapies, Inc. , a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, today.

United statesCameron radinovicJuan sanchezTd cowen health care conferenceCellular therapies incBurns mcclellan incGlobenewswire incCorporate communicationsCellular therapiesChief executive officerHealth care conferenceInvestor relations